AlarabHealth18:46

Israeli Government Approves National Plan to Boost Medical Research and Clinical Trials

By كل العرب

Translated & summarized from Alarab by baba

CommunityNeutral tone

Arabic · 6 newsrooms covering

Plus

The Israeli government has approved a national plan to boost medical research and clinical trials, presented by the Ministry of Health. The initiative aims to speed up the adoption of new treatments by reducing bureaucracy and streamlining approval processes. This move is expected to give patients earlier access to advanced therapies and attract international investment.

The story in 5 lines · by baba

Israel's government approved a national plan to enhance medical research and clinical trials.
The Ministry of Health presented the plan to accelerate innovative medical treatments for patients.
The initiative will reduce bureaucracy and implement a faster digital application system.
Mutual recognition of ethics committee approvals will be established between hospitals.
The plan aims to provide earlier access to new therapies and attract global investment.

Israeli Government Approves National Plan to Boost Medical Research and Clinical Trials — Editorial illustration generated by baba News, not a photograph of the event.

The Israeli government approved a comprehensive national plan on Sunday aimed at enhancing and expanding scientific research and clinical trials within the country. Presented by the Ministry of Health, the initiative is designed as a strategic move to accelerate the introduction of innovative medical technologies and treatments for patients.

The new plan includes measures to reduce bureaucratic procedures, redistribute authorities, and implement a rapid digital system for submitting applications. It also establishes an effective mechanism for mutual recognition of approvals from Helsinki committees (medical ethics and research committees) among different hospitals, intending to prevent duplication and shorten waiting and approval periods.

The Ministry of Health stated that this initiative will provide Israeli patients with earlier access to the latest therapeutic technologies and equip medical teams with advanced expertise. Furthermore, it is expected to bolster Israel's standing on the international health stage and attract substantial investments from major global pharmaceutical and biotechnology companies.